All women recorded hot flashes for 7 days before starting treatment and were then titrated to citalopram at daily target doses of 10 mg, 20 mg or 30 mg versus placebo to evaluate the change in ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...